In 166 patients (64.8%) the dose regimen of the factor Xa inhibitor prior to stroke onset followed the criteria of the EMA-labelling, 67 patients (26.2%) were classified as underdosed and 21 patients (8.2%) as overdosed. The gene discussed is F10; the disease is Stroke.